Inside The Report:
111 abstracts. 107 clinical studies. 4 preclinical programs. One expertly curated report.
- Therapeutic Class Trends: Deep insights into monovalent degraders, IMiDs, SERDs, molecular glues, and PROTACs
- Disease Focus: Strong signals in HR+ breast cancer and relapsed/refractory multiple myeloma
- Competitive Benchmarking: See how emerging programs stack up in the late-stage TPD space
You May Also Be Interested In…
Learn More About TPD
What is Beacon TPD?
- The Most Comprehensive Way to Search the TPD Drug Development Landscape: Unique search ontologies based on TPD drug and trial characteristics
- Market Leading Approach to TPD Preclinical & Clinical Data Curation: Manual curation of key TPD research and development data points by TPD research scientists
- Seamlessly Integrate Commercial & Scientific Data all in One Place: Search TPD company and deal data based on their pipeline and technologies.
- Unrivalled Granularity in Reports & Analysis: Our search ontology and technology indexing enable comprehensive analysis not seen elsewhere.
What is Beacon?
Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.
Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements
